Risk factors and prediction models for bronchitis obliterans after severe Mycoplasma pneumoniae pneumonia with

Fang Cheng1, Ruixue Sun2, Yingmian Zhao3

  • 1Fang Cheng, Department of Pediatrics, Xingtai People's Hospital, Xingtai Emergency Center, Xingtai 054000, Hebei, China.

Insights

Elevated lactate dehydrogenase is a risk factor for bronchitis obliterans in children with severe Mycoplasma pneumoniae pneumonia. Immunoglobulin A levels may protect against this condition, aiding in predictive model development.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Clinical Diagnostics

Background:

  • Severe Mycoplasma pneumoniae pneumonia (SMPP) can lead to complications like bronchitis obliterans in children.
  • Identifying risk factors for bronchitis obliterans is crucial for early intervention and improved outcomes.

Purpose of the Study:

  • To investigate risk factors associated with bronchitis obliterans in children diagnosed with SMPP.
  • To develop a predictive nomogram for identifying children at risk of developing bronchitis obliterans.

Main Methods:

  • A retrospective analysis of clinical data from 464 children with SMPP was conducted.
  • Children were categorized into bronchitis obliterans and simple pneumonia (PB) groups.
  • Statistical analysis, including chi-square and Mann-Whitney U tests, was performed using SPSS 26.0.

Main Results:

  • Lactate dehydrogenase (LDH) levels were significantly higher in children with bronchitis obliterans compared to those with PB.
  • Immunoglobulin A (IgA) levels were significantly lower in children with bronchitis obliterans.
  • Higher LDH was identified as an independent risk factor, while higher IgA was an independent protective factor.

Conclusions:

  • Elevated LDH is a significant independent risk factor for developing bronchitis obliterans in children with SMPP.
  • LDH and IgA demonstrate potential for a nomogram-based prediction model for bronchitis obliterans risk.
  • The findings support the development of targeted diagnostic and management strategies for SMPP complications.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
1
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
2
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.3K